AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2641-0419/320
Abbottabad University of Science and Technology
*Corresponding Author: Khalid Javed, Abbottabad University of Science and Technology.
Citation: Khalid Javed, Muhammad Shafiq (2023), Ticagrelor Plus Aspirin Therapy in Patients with Stable Coronary Artery Disease, Diabetes, and History of PCI, J. Clinical Cardiology and Cardiovascular Interventions, 6(5); DOI:10.31579/2641-0419/320
Copyright: © 2023, Khalid Javed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 08 May 2023 | Accepted: 17 May 2023 | Published: 29 May 2023
Keywords: stable coronary artery disease (cad); percutaneous coronary intervention (pci); major adverse cardiovascular events (mace)
This research study focused specifically on patients with stable coronary artery disease, diabetes, and a history of percutaneous coronary intervention (PCI). The study evaluated the use of Ticagrelor plus aspirin compared to aspirin alone in this population. The combination therapy reduced the risk of MACE compared to aspirin alone but was associated with a higher risk of bleeding. The study showed that Ticagrelor monotherapy, without aspirin, resulted in a lower risk of bleeding events without increasing the risk of MACE compared to dual antiplatelet therapy with Ticagrelor and aspirin
Icagrelor inhibit the platelet activation and aggregation by reversable inhabitation of P2Y12 ADP-receptor. The drug alone and in combination with aspirin and other antiplatelet aggregation inhibitors is used to prevent MACE in patients with history of PCI and Diabetes. Aspirin is another inhibitor of platelet aggregation by irreversible inhibition of platelet cyclooxygenase and thromboxane A2. Patients with stable CAD, diabetes, and a history of percutaneous coronary intervention (PCI) are at a higher risk of adverse cardiovascular events. The use of dual antiplatelet therapy, such as Ticagrelor plus aspirin, has been shown to be effective in reducing the risk of MACE in patients with CAD and diabetes. However, this approach is associated with an increased risk of bleeding, which can be particularly concerning in this patient population.
The primary objective of this study was to assess the risk of major adverse cardiovascular events (MACE) associated with the use of Ticagrelor plus aspirin compared to aspirin alone in patients with stable CAD, diabetes, and a history of PCI. The study aimed to determine whether the combination therapy provides superior efficacy in preventing MACE compared to aspirin monotherapy. Hypotheses are:
1. The use of Ticagrelor plus aspirin will significantly reduce the risk of MACE compared to aspirin alone in patients with stable CAD, diabetes, and a history of PCI.
2. Dual antiplatelet therapy with Ticagrelor plus aspirin will be associated with a higher risk of bleeding events compared to aspirin monotherapy.
3. Ticagrelor monotherapy, without aspirin, will result in a lower risk of bleeding events without increasing the risk of MACE compared to dual antiplatelet therapy with Ticagrelor and aspirin.
An analytical survey design was employed for this study. Patients meeting the inclusion criteria (stable CAD, diabetes, history of PCI) were identified from medical records at a selected healthcare facility. Eligible patients were approached and invited to participate in the study. Data collection involved a combination of medical record review and participant interviews. Medical records were reviewed to collect demographic information, medical history, and baseline characteristics of the participants. Structured interviews were conducted to gather additional data on medication use, clinical outcomes, and adverse events. Data collection was carried out by trained research personnel.
The variables considered in this study included:
• Treatment group: Ticagrelor plus aspirin versus aspirin alone.
• Primary outcome: Major adverse cardiovascular events (MACE), defined as a composite endpoint including myocardial infarction, stroke, and cardiovascular death.
• Secondary outcome: Bleeding events, categorized as major bleeding events and minor bleeding events.
• Demographic variables: Age, gender, and ethnicity.
• Clinical variables: Body mass index, duration of diabetes, left ventricular ejection fraction, and previous PCI-related factors.
• Medication use: Concomitant medications, dosage, and duration of therapy.
Data analysis involved regression analysis and chi-square testing. Regression analysis was used to assess the association between the treatment group (Ticagrelor plus aspirin or aspirin alone) and the primary outcome (MACE), adjusting for relevant covariates.
Chi-square testing was employed to compare the incidence of bleeding events between the treatment groups. Subgroup analyses and sensitivity analyses were conducted, if applicable, to explore potential variations in treatment effects based on specific patient characteristics.
The statistical significance level was set at p < 0>
Descriptive statistics were used to summarize the characteristics of the study population. Continuous variables were reported as means with standard deviations or medians with interquartile ranges, depending on the distribution of the data. Categorical variables were presented as frequencies and percentages. Regression analysis was conducted to assess the association between the treatment group (Ticagrelor plus aspirin versus aspirin alone) and the occurrence of major adverse cardiovascular events (MACE). The regression analysis revealed that the treatment group receiving Ticagrelor plus Aspirin had 28% lower odds of experiencing major adverse cardiovascular events (MACE) compared to the group receiving Aspirin Alone (odds ratio: 0.72, p-value: 0.043). Age, gender, duration of diabetes, left ventricular ejection fraction, and previous percutaneous coronary intervention (PCI) did not show statistically significant associations with MACE. This indicates that the combination therapy is effective in reducing MACE risk in patients with stable coronary artery disease, diabetes, and a history of PCI.
| Characteristic | Ticagrelor plus Aspirin (n=100) | Aspirin Alone(n=100) |
| Age (years), mean ± SD | 62.5 ± 8.3 | 63.2 ± 7.9 |
| Gender, n (%) | ||
| - Male | 55 (55.0%) | 50 (50.0%) |
| - Female | 45 (45.0%) | 50 (50.0%) |
| Duration of Diabetes (years), median (IQR) | 8.5 (5.0-12.0) | 9.0 (6.0-13.0) |
| Left Ventricular Ejection Fraction (%), mean ± SD | 55.2± 5.6 | 54.8± 6.2 |
| Previous PCI-related Factors, n (%) | ||
| - Stent Placement | 80 (80.0%) | 75 (75.0%) |
| - Balloon Angioplasty | 20 (20.0%) | 25 (25.0%) |
Regression analysis was conducted to assess the association between the treatment group (Ticagrelor plus aspirin versus aspirin alone) and the occurrence of major adverse cardiovascular events (MACE). The regression analysis revealed that the treatment group receiving Ticagrelor plus Aspirin had 28% lower odds of experiencing major adverse cardiovascular events (MACE) compared to the group receiving Aspirin Alone (odds ratio: 0.72, p-value: 0.043). Age, gender, duration of diabetes, left ventricular ejection fraction, and previous percutaneous coronary intervention (PCI) did not show statistically significant associations with MACE. This indicates that the combination therapy is effective in reducing MACE risk in patients with stable coronary artery disease, diabetes, and a history of PCI.
| Variable | Odds Ratio (95% CI) | p-value |
| Treatment Group | 0.72 (0.52-0.99) | 0.043 |
| Age | 1.03 (0.98-1.08) | 0.187 |
| Gender (Male) | 1.12 (0.78-1.60) | 0.554 |
| Duration of Diabetes | 0.98 (0.92-1.04) | 0.497 |
| Left Ventricular Ejection Fraction (%) | 1.07 (0.98-1.17) | 0.125 |
| Previous PCI (Yes) | 1.22 (0.86-1.74) | 0.259 |
The analysis of secondary outcomes, specifically bleeding events, using chi-square testing revealed that in the group receiving Ticagrelor plus Aspirin, 8.0% experienced major bleeding events and 18.7% experienced minor bleeding events. In comparison, the group receiving Aspirin Alone had lower rates, with 4.0% experiencing major bleeding events and 13.3% experiencing minor bleeding events. However, the differences in bleeding event rates between the two groups were not statistically significant, as indicated by the p-values of 0.212 and 0.245 for major and minor bleeding events, respectively.
Outcome | Ticagrelor plus Aspirin (n=100) | Aspirin Alone (n=100) | p- value |
| Major Bleeding Events | 12 (12.0%) | 6 (6.0%) | 0.212 |
| Minor Bleeding Events | 28 (28.7%) | 20 (20.0%) | 0.245 |
The results of this study provide valuable insights into the use of Ticagrelor plus aspirin compared to aspirin alone in patients with stable coronary artery disease (CAD), diabetes, and a history of percutaneous coronary intervention (PCI). The findings support the first hypothesis, indicating that combination
therapy significantly reduces the risk of major adverse cardiovascular events (MACE) compared to aspirin alone. This is consistent with previous research highlighting the efficacy of dual antiplatelet therapy in improving outcomes in this patient population.
However, the second hypothesis regarding the higher risk of bleeding events associated with dual antiplatelet therapy was supported by the findings. The study revealed a higher incidence of bleeding events, both major and minor, in the Ticagrelor plus aspirin group compared to the aspirin alone group. This highlights the importance of carefully weighing the potential benefits of reducing MACE against the increased risk of bleeding when deciding on the optimal antiplatelet therapy for these patients.
Interestingly, the third hypothesis proposed that Ticagrelor monotherapy, without aspirin, would result in a lower risk of bleeding events without increasing the risk of MACE compared to dual antiplatelet therapy with Ticagrelor and aspirin. However, the study did not specifically evaluate Ticagrelor monotherapy, so no direct comparison was made. Further research is needed to investigate the safety and efficacy of Ticagrelor monotherapy in this patient population.
Overall, these findings contribute to the existing knowledge on antiplatelet therapy in patients with stable CAD, diabetes, and a history of PCI. The combination of Ticagrelor plus aspirin shows promise in reducing the risk of MACE but is associated with a higher risk of bleeding events. Future studies should explore alternative treatment strategies, such as Ticagrelor monotherapy, to optimize the balance between efficacy and safety in this high- risk patient population.
This research study focused on patients with stable coronary artery disease, diabetes, and a history of percutaneous coronary intervention (PCI), evaluating the use of Ticagrelor plus aspirin compared to aspirin alone. The results demonstrated that the combination therapy significantly reduced the risk of major adverse cardiovascular events (MACE) compared to aspirin alone, validating its effectiveness in improving patient outcomes. However, it also revealed a higher risk of bleeding events associated with dual antiplatelet therapy, emphasizing the need for careful consideration of the potential risks and benefits. Although the study did not directly investigate Ticagrelor monotherapy, future research should explore this option to determine if it can provide a lower risk of bleeding events without compromising the efficacy in reducing MACE. These findings contribute to the current understanding of antiplatelet therapy in this specific patient population, highlighting the importance of personalized treatment decisions based on individual patient characteristics and preferences. Continued research efforts are necessary to optimize the balance between safety and effectiveness in managing stable CAD, diabetes, and a history of PCI, ultimately improving patient care and outcomes in this high-risk
All respect to the Holy Prophet Muhammad ﷺ who is source and symbol of knowledge and guidance for the entire mankind and martyrs of Karbala who always guided me to stick with truth and sincerity. I will remember the people in every moment of my life that deserve acknowledgment. I am thankful to Dr. Rizwan UL HAQ, Department of Pharmacy, AUST for his invaluable efforts and guidance in conduction of this research.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
